Edition:
United States

Arcturus Therapeutics Ltd (ARCT.OQ)

ARCT.OQ on NASDAQ Stock Exchange Global Market

8.19USD
15 Dec 2017
Change (% chg)

$-0.32 (-3.76%)
Prev Close
$8.51
Open
$8.61
Day's High
$8.61
Day's Low
$8.19
Volume
6,481
Avg. Vol
24,907
52-wk High
$17.99
52-wk Low
$5.81

Chart for

About

Arcturus Therapeutics Ltd, formerly Alcobra Ltd, is an Israel-based preclinical-stage biopharmaceutical company primarily focused on the discovery, development and commercialization of ribonucleic acid (RNA) medicines using lipid-mediated nanoparticle delivery system (LUNAR) and Unlocked Nucleomonomer Agent (UNA) Oligomer... (more)

Overall

Beta: 1.55
Market Cap(Mil.): $32.25
Shares Outstanding(Mil.): 3.94
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 198.20 16.04
EPS (TTM): -- -- --
ROI: -- -11.76 34.69
ROE: -- -36.72 15.46

Earnings vs. Estimates